Hospitals continued to be a stable and slightly growing source of jobs and wages in Indiana—for better and for worse.
The sector paid $7.3 billion to 127,000 Hoosiers in 2008, according to the latest data from the American Hospital Association.
Physician offices will begin receiving payments from the Medicare that are 21.3-percent below
what they’ve been getting so far this year. Doctors still expect Congress to reverse the payment cuts, but physicians
and the Medicare program will have to reprocess claims, costing both extra money.
Roche Holding AG’s decision to postpone its experimental diabetes drug is helping boost shares in Amylin Pharmaceuticals
Inc. and drug partner Eli Lilly and Co.
The giant drugmaker is in the process of trimming 35 percent—or about 19 people—from its 55-person communications
staff. Most of that staff is based in Indianapolis.
The Indiana Family and Social Services told Area Agencies on Aging that a 15-percent cut in funding for the program known
as CHOICE will save about $7.3 million from the program’s $48.8 million annual budget.
When WellPoint Inc. named Angela Braly its CEO three years ago, it touted her experience dealing with politicians and government
regulators. But WellPoint is now the poster child for health insurer bad behavior—credited in Washington with reviving a
dead health reform bill the company opposed.
Wellpoint has stuck to the $6-per-share forecast since January even after reporting that first-quarter net income jumped 51
percent, easily topping Wall Street expectations.
What recession? Some firms are enjoying explosive growth.
Health care, plastics, other fundamental consumer needs kept some companies on upswings.
One-time events influenced bottom lines of some of the few companies that made more money in 2009.
Few escaped the Great Recession unscathed, and unusual circumstances helped some appear as though they did.
U.S. regulators may phase in requirements on how much health insurers spend on medical care to avoid pushing plans out of
the market for people who buy their own coverage, WellPoint Inc.’s chief financial officer said Wednesday.
Dan Evans, president and CEO of Clarian Health, details his cure for losing sight of day-to-day operations, how
he gauges his effectiveness, and two bits of crucial advice.
The latest idea from Dr. James Spahn, an Indianapolis health care entrepreneur, should help hospitals and nursing homes do
a better job of preventing severe bedsores, or pressure ulcers. That’s good, because Medicare and private health insurers
increasingly won’t pay to treat them.
Medical technology companies employed 19,950 Hoosiers in 2007 and supported another 35,000 jobs in supplier companies, according
to an analysis funded by an industry trade group.
The Indianapolis-based Richard M. Fairbanks Foundation is contributing $20 million to support IUPUI’s effort to open
a school of public health.
One in five medical claims is processed inaccurately by commercial health insurers—and a unit of Indianapolis-based
WellPoint Inc. does even worse—often leaving physicians shortchanged, according to the nation's largest doctor's
group.
WellPoint plans to build a network of primary care doctors and specialists who will be available any time to consult with
patients.
Despite losses, company sees growth in its DailyMed pharmacy services, which packages the right dosages of prescriptions to
make it easier for patients to follow their regimens.
The federal government is currently doling out $1.1 billion in stimulus funds to pay for research that compares multiple medical
treatments against one another to determine which is most effective. Drug companies like Eli Lilly and Co. are wary that comparative-effectiveness
research could threaten their sales.
